Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20

1.

Two-year real-life efficacy, tolerability and safety of dimethyl fumarate in an Italian multicentre study.

Mallucci G, Annovazzi P, Miante S, Torri-Clerici V, Matta M, La Gioia S, Cavarretta R, Mantero V, Costantini G, D'Ambrosio V, Zaffaroni M, Ghezzi A, Perini P, Rossi S, Bertolotto A, Rottoli MR, Rovaris M, Balgera R, Cavalla P, Montomoli C, Bergamaschi R.

J Neurol. 2018 Aug;265(8):1850-1859. doi: 10.1007/s00415-018-8916-6. Epub 2018 Jun 14.

PMID:
29948245
2.

6-Month Effects of Fingolimod on Indexes of Cardiovascular Autonomic Control in Multiple Sclerosis.

Racca V, Rovaris M, Vaini E, Cavarretta R, Ferratini M, Toccafondi A, Di Rienzo M.

J Am Coll Cardiol. 2016 Nov 1;68(18):2027-2029. doi: 10.1016/j.jacc.2016.08.032. No abstract available.

3.

Diagnostic tools for assessment of urinary dysfunction in MS patients without urinary disturbances.

Ghezzi A, Mutta E, Bianchi F, Bonavita S, Buttari F, Caramma A, Cavarretta R, Centonze D, Coghe GC, Coniglio G, Del Carro U, Ferrò MT, Marrosu MG, Patti F, Rovaris M, Sparaco M, Simone I, Tortorella C, Bergamaschi R.

Neurol Sci. 2016 Mar;37(3):437-42. doi: 10.1007/s10072-015-2415-7. Epub 2015 Nov 27.

PMID:
26613723
4.

Response to letter regarding article 'Fingolimod effects on left ventricular function in multiple sclerosis'.

Racca V, Di Rienzo M, Cavarretta R, Toccafondi A, Vaini E, Ferratini M, Rovaris M.

Mult Scler. 2016 Apr;22(5):708-9. doi: 10.1177/1352458515600251. Epub 2015 Sep 10. No abstract available.

PMID:
26359278
5.

Fingolimod effects on left ventricular function in multiple sclerosis.

Racca V, Di Rienzo M, Cavarretta R, Toccafondi A, Vaini E, Ferratini M, Rovaris M.

Mult Scler. 2016 Feb;22(2):201-11. doi: 10.1177/1352458515587753. Epub 2015 Jun 3.

PMID:
26041795
6.

Oxidative stress is differentially present in multiple sclerosis courses, early evident, and unrelated to treatment.

Gironi M, Borgiani B, Mariani E, Cursano C, Mendozzi L, Cavarretta R, Saresella M, Clerici M, Comi G, Rovaris M, Furlan R.

J Immunol Res. 2014;2014:961863. doi: 10.1155/2014/961863. Epub 2014 Mar 26.

7.

Effects of elastic compression on hypomobility edema and fibrinolysis activation in multiple sclerosis.

Arpaia G, Bavera PM, Caputo D, Mendozzi L, Cavarretta R, Rovaris M, Agus GB, Belcaro G, Milani M, Ippolito E, Spezzigu G, Cimminiello C.

Panminerva Med. 2011 Sep;53(3 Suppl 1):71-4.

PMID:
22108480
8.

Atlas-based versus individual-based fiber tracking of the corpus callosum in patients with multiple sclerosis: reliability and clinical correlations.

Laganà MM, Ceccarelli A, Preti MG, Venturelli C, Sormani MP, Cavarretta R, Baselli G, Cecconi P, Caputo D, Rovaris M.

J Neuroimaging. 2012 Oct;22(4):355-64. doi: 10.1111/j.1552-6569.2011.00650.x. Epub 2011 Sep 13.

PMID:
22092885
9.

Detection of viral DNA sequences in the cerebrospinal fluid of patients with multiple sclerosis.

Mancuso R, Hernis A, Cavarretta R, Caputo D, Calabrese E, Nemni R, Ferrante P, Delbue S, Clerici M.

J Med Virol. 2010 May;82(6):1051-7. doi: 10.1002/jmv.21764.

PMID:
20419821
10.

Risk of deep venous thrombosis (DVT) in bedridden or wheelchair-bound multiple sclerosis patients: a prospective study.

Arpaia G, Bavera PM, Caputo D, Mendozzi L, Cavarretta R, Agus GB, Milani M, Ippolito E, Cimminiello C.

Thromb Res. 2010 Apr;125(4):315-7. doi: 10.1016/j.thromres.2009.06.023. Epub 2009 Jul 29.

PMID:
19640570
11.

Multiple sclerosis-associated retroviral agent (MSRV)-stimulated cytokine production in patients with relapsing-remitting multiple sclerosis.

Saresella M, Rolland A, Marventano I, Cavarretta R, Caputo D, Marche P, Perron H, Clerici M.

Mult Scler. 2009 Apr;15(4):443-7. doi: 10.1177/1352458508100840. Epub 2009 Feb 27.

PMID:
19251836
12.

A pilot trial of low-dose naltrexone in primary progressive multiple sclerosis.

Gironi M, Martinelli-Boneschi F, Sacerdote P, Solaro C, Zaffaroni M, Cavarretta R, Moiola L, Bucello S, Radaelli M, Pilato V, Rodegher M, Cursi M, Franchi S, Martinelli V, Nemni R, Comi G, Martino G.

Mult Scler. 2008 Sep;14(8):1076-83. doi: 10.1177/1352458508095828.

PMID:
18728058
13.

Cervical cord magnetization transfer ratio and clinical changes over 18 months in patients with relapsing-remitting multiple sclerosis: a preliminary study.

Charil A, Caputo D, Cavarretta R, Sormani MP, Ferrante P, Filippi M.

Mult Scler. 2006 Oct;12(5):662-5.

PMID:
17086915
14.

Extracorporeal photochemotherapy: a safety and tolerability pilot study with preliminary efficacy results in refractory relapsing-remitting multiple sclerosis.

Cavaletti G, Perseghin P, Dassi M, Cavarretta R, Frigo M, Caputo D, Stanzani L, Tagliabue E, Zoia C, Grimaldi M, Isella V, Rota S, Ferrarese C, Frattola L.

Neurol Sci. 2006 Apr;27(1):24-32.

PMID:
16688596
15.

Magnetization transfer magnetic resonance imaging and clinical changes in patients with relapsing-remitting multiple sclerosis.

Oreja-Guevara C, Charil A, Caputo D, Cavarretta R, Sormani MP, Filippi M.

Arch Neurol. 2006 May;63(5):736-40.

PMID:
16682543
16.

Programmed cell death of myelin basic protein-specific T lymphocytes is reduced in patients with acute multiple sclerosis.

Saresella M, Marventano I, Speciale L, Ruzzante S, Trabattoni D, Della Bella S, Filippi M, Fasano F, Cavarretta R, Caputo D, Clerici M, Ferrante P.

J Neuroimmunol. 2005 Sep;166(1-2):173-9.

PMID:
16161213
17.

Progressive gray matter damage in patients with relapsing-remitting multiple sclerosis: a longitudinal diffusion tensor magnetic resonance imaging study.

Oreja-Guevara C, Rovaris M, Iannucci G, Valsasina P, Caputo D, Cavarretta R, Sormani MP, Ferrante P, Comi G, Filippi M.

Arch Neurol. 2005 Apr;62(4):578-84.

PMID:
15824256
18.

Increased cytokine release from peripheral blood cells after acute stroke.

Ferrarese C, Mascarucci P, Zoia C, Cavarretta R, Frigo M, Begni B, Sarinella F, Frattola L, De Simoni MG.

J Cereb Blood Flow Metab. 1999 Sep;19(9):1004-9.

PMID:
10478652
19.

Effect of anticonvulsant drugs on peripheral benzodiazepine receptors of human lymphocytes.

Ferrarese C, Marzorati C, Perego M, Bianchi G, Cavarretta R, Pierpaoli C, Moretti G, Frattola L.

Neuropharmacology. 1995 Apr;34(4):427-31.

PMID:
7566474
20.

[Toxicomania in our country].

LEMBERG A, CAVARRETTA R, GOTLOIB L.

Rev Asoc Med Argent. 1962 Sep;76:428-33. Spanish. No abstract available.

PMID:
13929543

Supplemental Content

Loading ...
Support Center